We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Covovax

News List

Novavax, SII File COVID Vax EUA in South Africa contractpharma
January 10, 2022
If authorized, the vaccine will be manufactured by and commercialized by SII in South Africa under the brand name Covovax.
Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEO firstwordpharma
August 09, 2021
Serum Institute of India CEO Adar Poonawalla said he is hopeful that Covovax will be launched in October, depending on DCGI approvals, for adults and for children by the first quarter of 2022, as reported The Economic Times.
IMCR and SII collaborate to develop Novavax’s Covid-19 vaccine in India pharmaceutical-technology
November 13, 2020
Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have collaborated for clinical development of the Covid-19 vaccine, COVOVAX, by US-based firm Novavax and upscaled by SII.